Orchidaceae is the largest family of flowering plants with over 35000 species and 850 genera. About 3300 species of orchids are found in Malaysia and the diversity is highest in the Main, Keledang, Bintang and Tahan Ranges. Apart from being prized for their beauty, orchids have long been used by humans for medicinal purposes. Today the uses of orchids have been expanded to the food and cosmetics industries. Many cosmeceutical companies use orchid extracts as an active ingredient in their products. Previous studies provide riveting insights into the potential uses of orchid extracts as an active agent in cosmetics. This paper describes the cosmeceutical potential of orchids as an anti-aging, and skin moisturizing agent. Orchid extracts from Vanda coerulea and V. teres delay aging caused by reactive oxygen species (ROS) following UV irradiation through their antioxidant and anti-inflammatory activity. These extracts also show anti-aging properties by stimulating cytochrome c oxidase (complex IV), which is part of the electron transport chain in mitochondria. Stimulation of cytochrome c oxidase improves the respiratory function of mitochondria in keratinocytes. The presence of mucilage in orchids enables them to maintain skin hydration. Mucilage functions as a moisturizer and emollient due to its high water binding capacity. Additionally, orchid extracts provide skin hydration by stimulating aquaporin 3 (AQP3) and LEKTI protein expression. The presence of AQP3 leads to a five-fold increase in water permeability, which subsequently increases stratum corneum hydration. Increased LEKTI protein expression mediated by orchid extracts reduces the degradation of desmoglein-1 and enhances the structural function of desmosomes, which play important roles in preventing water evaporation.
DresslerRL. (1993) Phylogeny and Classification of the Orchid Family, Illustrated ed. Cambridge University Press, Melbourne, Australia.
2.
GutierérrezRMP. (2010) Orchids: A review of uses in Traditional Medicine, its phytochemistry and pharmacology. Journal of Medicinal Plants Research, 4, 592–638.
3.
ChaseMW, CameronKM, BarrettRL, FreudensteinJV. (2003) DNA data and Orchidaceae systematics: A new phylogenetic classification. In Orchid Conservation. Natural History Publications, Kota Kinabalu, Malaysia, 5, 69–89.
4.
HossainMM. (2010) Therapeutic orchids: Traditional uses and recent advances — An overview. Fitoterapia, 82, 102–140.
5.
TurnerIM. (1996) Species loss in fragments of tropical rain forest: a review of the evidence. Journal of Applied Ecology, 200–209.
6.
SeidenfadenG, WoodJJ, HolttumRE. (1992) The Orchids of Peninsular Malaysia and Singapore. Olsen & Olsen, Fredensborg, Denmark.
ShahrilKZ. (1999) Highland Orchids of Peninsular Malaysia. World Wide Fund for Nature Malaysia, Petaling Jaya, Malaysia.
9.
KamarulzamanS. (1998) Orchid survey of Cameron Highlands. A preliminary checklist and considerations for conservations. Tabung Alam Malaysia, Petaling Jaya, Project Report.
10.
CribbPJ, KellSP, DixonKW, BarrettRL. (2003) Orchid conservation: a global perspective. Orchid conservation.Natural History Publications, Kota Kinabalu, 1–24.
11.
BatemanRM, RudallPJ. (2002) Roles of synorganisation, zygomorphy and heterotopy in floral evolution: the Gynostemium and Labellum of orchids and other lilioid monocots. Biological Reviews of the Cambridge Philosophical Society, 77, 403–441
12.
Mondragon-PalominoM, TheiBenG. (2008) MADS about the evolution of orchid flowers. Trends in Plant Sciences, 13, 51–59.
13.
Mondragon-PalominoM, TheiBenG. (2009) Why are orchid flowers so diverse? Reduction of evolutionary constraints by paralogues of class B floral homeotic genes. Annals of Botany, 104, 83–594.
14.
BhattD, SharmaP, SharmaL, JoshiGC. (2012) Folk herbal remedies for skin care in Kumaun Himalaya. Journal of Nin-Timber Forest Products, 19, 309–312.
15.
KongJM, GohNK, ChiaLS, ChiaTF. (2003) Recent advances in traditional plant drugs and orchids. Acta Pharmacologica Sinica, 24, 7–21.
16.
HutchingsA, ScottAH, LewisG, CunninghamAB. (2012) Zulu Medicinal Plants: An Inventory. Natal University Press, Pietermaritzburg.
17.
ChughS, GuhaS, RaoIU. (2009) Micropropagation of orchids: A review on the potential of different explants. Scientia Horticulturae, 122, 507–520.
18.
YonzoneR, LamaD, BhujelRB, RaiS. (2013) Present availability status, diversity resources and distribution of medicinal orchid species in Darjeeling Himalaya of West Bengal, India. International Journal of Pharmacy and Natural Medicines, 1, 14–35.
19.
SimmlerC, AntheaumeC, AndréP, BontéF, LobsteinA. (2011) Glucosyloxybenzyl eucomate derivatives from Vanda teres stimulate HaCaT cytochrome c oxidase. Journal of Natural Products, 74, 949–955.
20.
AndreP, ArchambaultJC, RenimelI. (2011) U.S. Patent No. 8,039,028. U.S. Patent and Trademark Office, Washington, DC.
21.
SakuraM, ChibaY, KamiyaE, FurukawaA, KawamuraN, NiwaM, TakeuchiM, EnokidoY, HosokawaM. (2014) Differences in the histopathology and cytokine expression pattern between chronological aging and photoaging of hairless mice skin. Modern Research in Inflammation, 3, 82–89.
22.
FisherGJ, WangZ, DattaSC, VaraniJ, KangS, VoorheesJJ. (1997) Pathophysiology of premature skin aging induced by ultraviolet light. New England Journal of Medicine, 337, 1419–1429.
23.
RabeJH, MamelakAJ, McElgunnPJS, MorisonWL, SauderDN. (2006) Photoaging: Mechanisms and repair. Journal of the American Academy of Dermatology, 55, 1–19.
24.
LeydenJJ. (1990) Clinical features of ageing skin. British Journal of Dermatology, 122, 1–3.
25.
FisherGJ, KangS, VaraniJ, Bata-CsorgoZ, WanY, DattaS, VoorheesJJ. (2002) Mechanisms of photoaging and chronological skin aging. Archives of Dermatology, 138, 1462–1470.
26.
YaarM. (1997) Clinical and histological features of intrinsic versus extrinsic skin aging. In Skin Aging, PhilippM. (Ed). Springer, Berlin, Germany. pp. 9–21.
27.
GilchrestBA, KrutmannJ. (2006) Photoaging of skin. In Skin Aging. Springer, Berlin, Heidelberg, pp. 33–44.
GoldsmithLA. (1991) Physiology, Biochemistry, and Molecular Biology of the Skin, 2nd ed. Oxford University Press, New York.
30.
LiuX, WuH, ByrneM, JeffreyJ, KraneS, JaenischR. (1995) A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. The Journal of Cell Biology, 130, 227–237.
31.
BakerAH, EdwardsDR, MurphyG. (2002) Metalloproteinase inhibitors: Biological actions and therapeutics opportunities. Journal of Cell Science, 115, 3719–3727.
32.
KawasumiA, SagawaN, HayashiS, YokoyamaH, TamuraK. (2013) Wound healing in mammals and amphibians: Toward limb regeneration in mammals In New Perspectives in Regeneration. Springer, Berlin, Heidelberg, pp. 33–49.
33.
PandelR, PoljsakB, GodicA, DahmaneR. (2013) Skin photoaging and the role of antioxidants in its prevention. Hindawi, 1–11.
34.
BickersDR, MohammadA. (2006) Oxidative stress in the pathogenesis of skin disease. Journal of Investigative Dermatology, 126, 2565–2575.
35.
RigellDS, WeissRA, LimHW, DoverJS. (2004) Photoaging Basic and Cinical Dermatology. CRC Press, New York, USA.
36.
FarageMA, MillerKW, MaibachHI. (Eds). (2010) Textbook of Aging Skin. Springer Science & Business Media, USA.
37.
BarfordD, JiaZ, TonksNK. (1995) Protein tyrosine phosphatases take off. Nature Structural Biology, 2, 1043–1053.
38.
HuangC, MaW, BowdenGT, DongZ. (1997) Ultraviolet B-induced activated protein-1 activation does not require epidermal growth factor receptor but is blocked by a dominant negative PKC l/i. The Journal of Biological Chemistry, 271, 31262–31268.
39.
RittieL, FisherGJ. (2002) UV-light-induced signal cascades and skin aging. Ageing Research Review, 1, 705–720.
40.
SimmlerC, AntheaumeC, LobsteinA. (2010) Antioxidant biomarkers from Vanda coerulea stems reduce irradiated HaCaT PGE-2 production as a result of COX-2 inhibition. Plos One, 5, 1–9.
SeoJY, KimEK, LeeSH, ParkKC, KimKH, EunHC, ChungJH. (2003) Enhanced expression of cylooxygenase-2 by UV in aged human skin in vivo. Mechanisms of Ageing and Development, 124, 903–910.
43.
RhodesLE, BelgiG, ParslewR, McLoughlinL, CloughGF, FriedmannPS. (2001) Ultraviolet-B-induced erythema is mediated by nitric oxide and prostaglandin E2 in combination. Journal of Investigative Dermatology, 117, 880–885.
44.
MasakiH. (2010) Role of antioxidants in the skin: anti-aging effects. Journal of Dermatological Science, 58, 85–90.
45.
SimmlerC, LobsteinA, LeplanquaisV, AndréP, ArchambaultJC, BontéF. (2009) In vitro anti-inflammatory and antioxidant activities of stilbenoids of Vanda coerulea (Orchidaceae), Planta Medica, 75, P12.
46.
JulsrigivalJ, SongsakT, KirdmaneeC, ChansakaowS. (2013) Determination of volatile constituents of Thai fragrant orchids by gas chromatography-mass spectrometry with solid-phase microextraction. Journal of Natural Sciences, 12, 43–57.
47.
TatsuzawaF, SaitoN, SekiH, YokoiM, YukawaT, ShinodaK, HondaT. (2004) Acylated anthocyanins in the flowers of Vanda (Orchidaceae). Biochemical Systematics and Ecology, 32, 651–664.
48.
RahmanMM, KonishiT. (2008) Anthocyanins as antioxidant. In Anthocyanins as Food Factor: Recent Progress in Studies on Bioavailability and Health Promotion Effects. KonishiT, IchiyanagiT. (Eds). Research Signpost, pp. 59–77.
49.
NicholsJA, KatiyarSK. (2010) Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Archives of Dermatological Research, 302, 71–83.
50.
GerardF, LeplanquaisV, PecherV, SauvanN. (2008) U.S. Patent Application 12/745,654. U.S. Patent and Trademark Office, Washington, DC.
51.
GardinerLM, KocyanA, MotesM, RobertsDL, EmersonBC. (2013) Molecular phylogenetics of Vanda and related genera (Orchidaceae). Botanical Journal of the Linnean Society, 173, 549–572.
52.
EckertRL, SturnioloMT, BroomeAM, RuseM, RorkeEA. (2005) Transglutaminase function in epidermis. Journal of Investigative Dermatology, 124, 481–492.
53.
HoganMB, PeeleK, WilsonNW. (2012) Skin barrier function and its importance at the start of the atopic march. Journal of Allergy, 2012, 1–17.
54.
LuebberdingS, KruegerN, KerscherM. (2013) Age-related changes in skin barrier function–Quantitative evaluation of 150 female subjects. International Journal of Cosmetic Science, 35, 183–190.
55.
MenonGK, Dal FarraC, BottoJM, DomlogeN. (2010) Mitochondria: a new focus as an anti-aging target in skin care. Journal of Cosmetic Dermatology, 9, 122–131.
56.
LanzaIR, NairKS. (2010) Mitochondrial function as a determinant of life span. Pflügers Archiv-European Journal of Physiology, 459, 277–289.
57.
SimmlerC, LeplanquaisV, NoblesseE, AndreP, LobsteinA. (2011) U.S. Patent Application 13/639,997. U.S. Patent and Trademark Office, Washington, DC:.
58.
CapaldiRA. (1990) Structure and function of cytochrome c oxidase. Annual Review of Biochemistry, 59, 569–596.
59.
SharovVG, TodorAV, ImaiM, SabbahHN. (2005) Inhibition of mitochondrial permeability transition pores by cyclosporine A improves cytochrome C oxidase function and increases rate of ATP synthesis in failing cardiomyocytes. Heart Failure Reviews, 10, 305–310.
60.
TortoraGJ, DerricksonB. (2011). Principles of Anatomy & Physiology Volume 1, 13th ed. John Wiley & Sons, Inc., New York.
61.
BarcoD, Giménez-ArnauA. (2008) Xerosis: a dysfunction of the epidermal barrier. Actas Dermo-Sifiliográficas (English Edition), 99, 671–682.
62.
Gimenez-ArnauAM. (2014) Xerosis means dry skin: Mechanisms, skin conditions and its management. In Filaggrin: Basic Science, Epidemiology, Clinical Aspects and Management, ThyssenJP, MaibachHI. (Eds). Springer, Berlin Heidelberg, pp. 235–250.
63.
LevequeJL, GroveG, De RigalJ, CorcuffP, KligmanAM, Saint LegerD. (1987) Biophysical characterization of dry facial skin. Journal of Society of Cosmetics Chemists, 82, 171–177.
64.
RawlingsAV, MattsPJ. (2005) Stratum corneum moisturization at the molecular level: an update in relation to the dry skin cycle. The Journal of Investigative Dermatology, 124, 1099–110.
65.
FowlerJ. (2012) Understanding the role of natural moisturizing factor in skin hydration. Practical Dermatology, pp. 36–40.
66.
PonecM, WeerheimA, LankhorstP, WertzP. (2003) New acylceramide in native and reconstructed epidermis. Journal of Investigative Dermatology, 120, 581–588.
HoffmannD. (2003) Medical Herbalism: The Science and Practice of Herbal Medicine. Inner Traditions, Vermont.
69.
IsraelR. (1991) The Natural Pharmacy Product Guide. Penguin, New York.
70.
MalviyaR, SrivastavaP, KulkarniGT. (2011) Applications of mucilages in drug delivery-A review. Advances in Biological Research, 5, 1–7.
71.
AburjaiT, NatshehFM. (2003) Plants used in cosmetics. Phytotherapy Research, 17, 987–1000.
72.
Hara-ChikumaM, VerkmanAS. (2008) Roles of aquaporin-3 in the epidermis. Journal of Investigative Dermatology, 128, 2145–2151.
73.
SougratR, MorandM, GondranC, BarreP, GobinR, BontéF, DumasM, VerbavatzJM. (2002) Functional expression of AQP3 in human skin epidermis and reconstructed epidermis. Journal of Investigative Dermatology, 118, 678–685.
74.
Boury-JamotM, SougratR, TailhardatM, VarletBL, BonteF, DumasM, VerbavatzJM. (2006) Expression and function of aquaporins in human skin: Is aquaporin-3 just a glycerol transporter?Biochimica et Biophysica Acta (BBA)-Biomembranes, 1758, 1034–1042.
75.
YangB, VerkmanAS. (1997) Water and glycerol permeabilities of aquaporins 1–5 and MIP determined quantitatively by expression of epitope-tagged constructs in Xenopus oocytes. Journal of Biological Chemistry, 272, 16140–16146.
76.
VerkmanAS. (2009) Aquaporins: translating bench research to human disease. Journal of Experimental Biology, 212, 1707–1715.
77.
MaT, HaraM, SougratR, VerbavatzJM, VerkmanAS. (2002) Impaired stratum corneum hydration in mice lacking epidermal water channel aquaporin-3. Journal of Biological Chemistry, 277, 17147–17153.
78.
CauchardJH, ArchambaultJC, LazouK, BonteF. (2012) U.S. Patent No. 8,293,287. U.S. Patent and Trademark Office, Washington, DC.
79.
Hara-ChikumaM, VerkmanAS. (2008) Prevention of skin tumorigenesis and impairment of epidermal cell proliferation by targeted aquaporin-3 gene disruption. Molecular and Cellular Biology, 28, 326–332.
80.
VerkmanAS. (2008) A cautionary note on cosmetics containing ingredients that increase aquaporin 3 expression. Experimental Dermatology, 17, 871–872.
81.
BitounE, MicheloniA, LamantL, BonnartC, Tartaglia-PolciniA, CobboldC, Al-SaatiT, MariottiF, Mazereeuw-HautierJ, BoraleviF, HohlD, HarperJ, BodemerC, D'AlessioM, HovnanianA. (2003) LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Human Molecular Genetics, 12, 2417–2430.
82.
DeraisonC, BonnartC, LopezF, BessonC, RobinsonR, JayakumarA, WagbergF, BrattsandM, HachemJP, LeonardssonG, HovnanianA. (2007) LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Molecular Biology of the Cell, 18, 3607–3619.
83.
RaghunathM, TontsidouL, OjiV, AufenvenneK, Schürmeyer-HorstF, JayakumarA, StanderH, SmolleJ, ClaymanGL, TraupeH. (2004) SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases. Journal of Investigative Dermatology, 123, 474–483.
84.
KomatsuN, TakataM, OtsukiN, OhkaR, AmanoO, TakeharaK, SaijohK. (2002) Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. Journal of Investigative Dermatology, 118, 436–443.
85.
BrattsandM. (2012) Kallikrien-related peptidases and inhibitors of the skin, In Characterization, Regulation, and Interactions within The Protease Web, MagdolenV, SommerhoffCP, FritzH, SchmittM. (Eds). Walter de Gruyter, Berlin, Germany, pp. 329–348.
86.
GarrodD, ChidgeyM. (2008) Desmosome structure, composition and function. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1778, 572–587.
87.
Verdier-SévrainS, BontéF. (2007) Skin hydration: a review on its molecular mechanisms. Journal of Cosmetic Dermatology, 6, 75–82.
